2 ,3 - Epithio-5 -androstan-17 -ol in the treatment of advanced breast cancer.
D000731:Androstanes / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004965:Estrogen Antagonists; D005260:Female; D006801:Humans; D006914:Hydroxysteroids / Q000008:administration & dosage / Q000627:therapeutic use; D007273:Injections, Intramuscular; D012075:Remission, Spontaneous; D013440:Sulfides / Q000008:administration & dosage / Q000627:therapeutic use; D013739:Testosterone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000731:Androstanes; D004965:Estrogen Antagonists; D006914:Hydroxysteroids; D013440:Sulfides; D013739:Testosterone